APA (7th ed.) Citation

Milton, D. T., Azzoli, C. G., Heelan, R. T., Venkatraman, E., Gomez, J. E., Kris, M. G., . . . Miller, V. A. (2006). A phase I/II study of weekly high‐dose erlotinib in previously treated patients with nonsmall cell lung cancer. Cancer, 107(5), 1034-1041. https://doi.org/10.1002/cncr.22088

Chicago Style (17th ed.) Citation

Milton, Daniel T., et al. "A Phase I/II Study of Weekly High‐dose Erlotinib in Previously Treated Patients with Nonsmall Cell Lung Cancer." Cancer 107, no. 5 (2006): 1034-1041. https://doi.org/10.1002/cncr.22088.

MLA (9th ed.) Citation

Milton, Daniel T., et al. "A Phase I/II Study of Weekly High‐dose Erlotinib in Previously Treated Patients with Nonsmall Cell Lung Cancer." Cancer, vol. 107, no. 5, 2006, pp. 1034-1041, https://doi.org/10.1002/cncr.22088.